Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

生物技术研究

Seattle,Washington 40,013 位关注者

Focused on creating and delivering engineered cells as medicines for patients

关于我们

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body. We are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. Next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. Last is a belief we can enable broader access to our therapies through focusing on scalable manufacturing solutions, the cost of manufacturing, and aligning with key stakeholders. Sana launched in early 2019 and has over 350 employees in Seattle, Cambridge, and South San Francisco. Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of using engineered cells to meaningfully change the outcome of many human diseases.

网站
https://sana.com
所属行业
生物技术研究
规模
201-500 人
总部
Seattle,Washington
类型
上市公司
创立
2018

地点

  • 主要

    188 E Blaine St

    Suite 400

    US,Washington,Seattle,98102

    获取路线
  • 1 Tower Pl

    Suite 500

    US,California,South San Francisco,94080

    获取路线
  • 300 Technology Sq

    Suite 700

    US,Massachusetts,Cambridge,02139

    获取路线

Sana Biotechnology, Inc.员工

动态

相似主页

查看职位

融资